TransMolecular Presents Imaging and Pharmacokinetic Analysis of 131Iodine-TM601 at Society for Nuclear Medicine Meeting

kavin submitted, created time 6 months 3 weeks (www.businesswire.com)

TM601 is a novel synthetic peptide targeting both primary tumors and metastases and it will give us some hope in the battle against cancer. Derived from scorpion venom, TM601 binds to receptors on cancer cells but leaves healthy cells alone. When TM601 is tagged with radioactive iodine, it can deliver a tiny, targeted dose of radiation to cancer cells, killing them while leaving healthy tissue unharmed.

The potential of TM601 is so high that the FDA has granted its iodine-labeled form orphan drug status for patients with malignant gliomas

2 comments | Blog It | Email It | Keywords: radiation therapy cancer anti-angiogenic orphan drug status orphan drugs gliomas TM601 nuclear medicine